About this trial
The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
GnRH antagonist IVF cycle
Hyper-responders to induction of ovulation
Disqualifiers
Hypogonadotrophic hypogonadism
Endometriosis
History of recurrent abortion
Trial design
Parallel
Treatments tested in this trial
Successive doses GnRH agonist
DrugGnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) is administered 36 hours before ovum pickup. Two additional doses of triptorelin ( 0.1 mg / S.C ) are administered subcutaneously 12 and 24 hours after the first dose of GnRH agonist.
Single dose GnRH agonist
DrugGnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) is administered 36 hours before ovum pickup.
Treatment groups
Trial outcomes
Primary outcomes
Metaphase-II oocytes rate
Number of MII oocyte/ number of cumulus oocyte complex
Secondary outcomes
Clinical pregnancy rate
Presence of intrauterine gestational sac detected by transvaginal ultrasound
Ongoing pregnancy Rate
Pregnancies continued beyond 20 weeks gestation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: